Abott’s new partner for digestive disorder treatment, ‘Green Cross’

Published: 2017-10-17 16:41:52

Updated: 2017-10-17 16:41:52

Abott and Green Cross have attracted the industry as establishing a common front in the Korean digestive disorder treatment market.

‘Ganaton Tab’ Abott Korea has directly sold after acquiring its license from a Korean pharmaceutical company in 2015 will be distributed in Korea through Green Cross.

Recently, Abott Korea informed its partnering companies that a supplier of ‘Ganaton Tab 50mg(ind...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.